Oxidative stress is not involved in motion sickness in mice

CNS Neuroscience and Therapeutics

Volumn 19, Issue 8, 2013, Pages 611-616

  Wang, Zhi Bin ^a   Han, Ping ^a   Tu, Ye ^a   Liu, Wei Ye ^a   Tao, Bei Lei ^b   Zhang, Li Chao ^b   Li, Ling ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI SEVENTH PEOPLE S HOSPITAL   (China)

Author keywords

Mice; Motion sickness; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTAMIC ACID; MESSENGER RNA; PARAQUAT; PEROXIREDOXIN 6; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN CORTEX; BRAIN REGION; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; ENZYME ACTIVITY; MALE; MOTION SICKNESS; MOUSE; NONHUMAN; OXIDATIVE STRESS; ROTATION; VESTIBULAR NUCLEUS;

MICE; MOTION SICKNESS; OXIDATIVE STRESS;

ANIMALS; ANTIOXIDANTS; BRAIN; MALE; MICE; MICE, INBRED C57BL; MOTION SICKNESS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84880668856     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12115     Document Type: Article

References (29)

1. Golding JF. Motion sickness susceptibility. Auton Neurosci 2006;129:67-76.
2. Shupak A, Gordon CR. Motion sickness: advances in pathogenesis, prediction, prevention, and treatment. Aviat Space Environ Med 2006;77:1213-1223.
3. Watt DG. Sensory and motor conflict in motion sickness. Brain Behav Evol 1983;23:32-35.
4. Wood CD, Graybiel A. A theory of motion sickness based on pharmacological reactions. Clin Pharmacol Ther 1970;11:621-629.
5. Treisman M. Motion sickness: an evolutionary hypothesis. Science 1977;197:493-495.
6. Devi PU, Saraogi P, Manocha A, Vohora D. Pharmacological and biochemical analysis of interactions between N-acetylcysteine and some antiepileptic drugs on experimental seizures in mice. CNS Neurosci Ther 2012;18:406-413.
7. Alp R, Selek S, Alp SI, Taskin A, Kocyigit A. Oxidative and antioxidative balance in patients of migraine. Eur Rev Med Pharmacol Sci 2010;14:877-882.
8. Caviness JN, Lue L, Adler CH, Walker DG. Parkinson's disease dementia and potential therapeutic strategies. CNS Neurosci Ther 2011;17:32-44.
9. Kincses ZT, Vecsei L. Pharmacological therapy in Parkinson's disease: focus on neuroprotection. CNS Neurosci Ther 2011;17:345-367.
10. Yilmaz G, Surer H, Inan LE, Coskun O, Yucel D. Increased nitrosative and oxidative stress in platelets of migraine patients. Tohoku J Exp Med 2007;211:23-30.
11. Bernecker C, Ragginer C, Fauler G, et al. Oxidative stress is associated with migraine and migraine-related metabolic risk in females. Eur J Neurol 2011;18:1233-1239.
12. Shimomura T, Kowa H, Nakano T, et al. Platelet superoxide dismutase in migraine and tension-type headache. Cephalalgia 1994;14:215-218.
13. Ciancarelli I, Tozzi-Ciancarelli MG, Spacca G, Di Massimo C, Carolei A. Relationship between biofeedback and oxidative stress in patients with chronic migraine. Cephalalgia 2007;27:1136-1141.
14. Cuomo-Granston A, Drummond PD. Migraine and motion sickness: what is the link? Prog Neurobiol 2010;91:300-312.
15. Goto F, Hayashi K, Kunihiro T, Ogawa K. The possible contribution of angiitis to the onset of benign paroxysmal positional vertigo (BPPV). Int Tinnitus J 2010;16:25-28.
16. Yu XH, Cai GJ, Liu AJ, Chu ZX, Su DF. A novel animal model for motion sickness and its first application in rodents. Physiol Behav 2007;92:702-707.
17. Wei X, Wang ZB, Zhang LC, Liu WY, Su DF, Li L. Verification of motion sickness index in mice. CNS Neurosci Ther 2011;17:790-792.
18. Wang ZB, Tu Y, Liu WY, et al. Motion sickness induces intestinal transit increase in mice. CNS Neurosci Ther 2013;19:132-133.
19. Zhang XH, Lei H, Liu AJ, Zou YX, Shen FM, Su DF. Increased oxidative stress is responsible for severer cerebral infarction in stroke-prone spontaneously hypertensive rats. CNS Neurosci Ther 2011;17:590-598.
20. Angelaki DE, Cullen KE. Vestibular system: the many facets of a multimodal sense. Annu Rev Neurosci 2008;31:125-150.
21. Balaban CD, Porter JD. Neuroanatomic substrates for vestibulo-autonomic interactions. J Vestib Res 1998;8:7-16.
22. Eisenman LM. Motion sickness may be caused by a neurohumoral action of acetylcholine. Med Hypotheses 2009;73:790-793.
23. Huang HF, Guo F, Cao YZ, Shi W, Xia Q. Neuroprotection by manganese superoxide dismutase (MnSOD) mimics: antioxidant effect and oxidative stress regulation in acute experimental stroke. CNS Neurosci Ther 2012;18:811-818.
24. Bockowski L, Sobaniec W, Kulak W, Smigielska-Kuzia J. Serum and intraerythrocyte antioxidant enzymes and lipid peroxides in children with migraine. Pharmacol Rep 2008;60:542-548.
25. Baranenko VV. Effect of clinorotation on the intensity of lipid peroxidation and superoxide dismutase activity in pea chloroplasts. Tsitologiia 2001;43:1020-1023.
26. Baranenko VV. Pea chloroplasts under clino-rotation: lipid peroxidation and superoxide dismutase activity. Adv Space Res 2001;27:973-976.
27. Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature 1993;364:535-537.
28. de Waele C, Muhlethaler M, Vidal PP. Neurochemistry of the central vestibular pathways. Brain Res Brain Res Rev 1995;20:24-46.
29. Cai YL, Ma WL, Li M, et al. Glutamatergic vestibular neurons express Fos after vestibular stimulation and project to the NTS and the PBN in rats. Neurosci Lett 2007;417:132-137.